Sixty Six Oilfield Services Inc (SSOF)

[specul8r]

MMHC STATEMENT FROM NEW CEO

Apr 22, 2016
OTC Disclosure & News Service

St. Thomas, VI -

Medically Minded CEO Issues Statement



ST. THOMAS, U.S. VIRGIN ISLANDS--(April 22, 2016) - Medically Minded, Inc. (OTC PINK: MMHC), newly elected CEO released the following statement today:



"It is with great pleasure that I have been retained as CEO to lead Medically Minded's entry into the Hemp CBD, medical marijuana and alternative medicine industry. There were several revisions that needed to be made to the Company's initial business model for entering these markets. The original model was focused on medical marijuana legislation in the U.S.Virgin Islands and capitalizing on the revenue potential once legislation passed. In my opinion, this approach required large amounts of capital and time while putting revenues on the back end.



Our revised business model puts the focus on products already legal (Hemp CBD is legal in all States), therefore requiring less upfront capital and generating revenues immediately. The contacts, relationships, credibility, distribution and revenues we will potentially generate through marketing of these products will prove to be beneficial in our continued pursuit of opportunities within the medical marijuana space.



As part of this revised plan, the Company and Stephen Jones agreed that it would be best for Medically Minded U.S.V.I. ("MMUSVI") to continue its efforts outside of MMHC. This will allow Mr. Jones and MMUSVI to focus efforts solely on the U.S. Virgin Islands legislation. The Company and Mr. Jones will continue to work together on potential opportunities for both companies as legalization comes to pass and the industry evolves in the Islands.



In moving forward with our current business model we have taken several exciting steps. Our subsidiary, Medically Minded International,will market Hemp CBD and other natural based products under our brand Medically Minded. We will also market 3rd party products for companies we have established a distribution relationship with. Our logo for the Medically Minded products can be seen at our soon to be launched E-commerce storefront (www.medmindedlabs.com) .



We expect our E-commerce storefront (www.medmindedlabs.com) to be open early next week and will initially feature several products that we have acquired for resale through arrangements with World Hemp Oil (www.worldhempoil.com). The products we will launch with include Hemp CBD Honey Sticks, Hemp CBD Vape Oil 10ml (in 3 flavors and either 50ml CBD or 150ml CBD), Hemp CBD infused shampoo, Hemp CBD infused conditioner and Hemp CBD infused body lotion. We expect to acquire Hemp CBD Oil and various other products from World Hemp Oil and two other suppliers that will be added to our storefront ongoing over the next several weeks. Our private label products should be available over the next 14-21 days depending on the label process.



In regards to other updates , we are working aggressively with Mr. Ken Sobel to define a plan of action for his involvement with moving the Company's model forward. Mr. Sobel is in favor of the revised business model and possesses an extensive network of potential distribution channels and CBD suppliers. Additionally, the growth of our hemp cbd sales will allow the Company to capitalize on the opportunities and the network in the medical marijuana space that Mr. Sobel brings to our team.



To summarize, our storefront launches next week, our brand labels are in process, we have secured several private label suppliers (that will be disclosed as our product is released), we have secured initial inventory through World Hemp Oil and we have arranged for distribution relationships with two product lines. We see product development and marketing as the keys to our success. As our product line continues to progress we are actively establishing marketing programs that will be launched with our storefront.



In closing, I want the shareholders to know that my plan is to build shareholder value through sales, growth and profits. Medically Minded is at a very exciting time in an emerging growth industry. It is our goal to capitalize on this emerging industry for our shareholders, investors, customers and partners. As a long time investor, shareholder, executive and consultant with micro cap companies I understand the frustrations and concerns of the market. I also understand the importance of communication, regular updates and the need to build a profitable business to truly increase shareholder value. While profits and success are unable to be guaranteed, I can assure the shareholders that the effort and regular communication of that effort will be."





About Cannabidiol (“CBD”) Oil



CBD Rich Hemp Oil is an oil extracted from Industrial Hemp plants (stalks and seeds) with a High Grade of Cannabidiol (CBD). The plants used are specifically and uniquely bred to comprise high concentrations of the naturally occurring Cannabinoid Cannabidiol (CBD). Cannabidiol oil that comes from industrial hemp plants, such as will be the case with our products, are considered by the FDA to be a dietary supplement (not a medication) since they are made from industrial hemp plants.



If you live in the US, this means you don’t need a prescription and can legally purchase and consume Cannabidiol in any state. Cannabidiol from industrial hemp also has the added benefit of having virtually no THC. This is why it’s not possible to get “high” with these products. There simply isn’t enough THC.



FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program.

FORWARD LOOKING DISCLAIMER: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk facts that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.



Contact:

[e-mail]

Copyright © 2016 OTC Markets. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.